On April 25, 2018, Lifetech was included in the ranking of the "the Most Attentive List Company by Institution Investors of Shenzhen-Hongkong Stock Connect " which was jointly organized by Yuediaoyan.com and Gelonghui.com with support from Hong Kong Exchanges and Clearing Limited and Euroland IR.
The launch of the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect allow mainland investors to participate in the Hong Kong securities market, which not only increases the activity of the Hong Kong securities market, but also creates a broad platform and opportunities for outstanding benchmark companies for the Hong Kong Stock Connect. To date, more than 10% of Lifetech's shares have been traded through Southbound Trading, representing a market value of nearly HK$1 billion.
(Fig.: Mr. Zhu Shengli, Director of Investor Relations of Lifetech (sixth from right) accepted the award on behalf of the company)
The award will undoubtedly increase the appeal of the company to mainland investors. Lifetech will continue to focus on the sustainable development of its core business, and share the medical market worth billions with shareholders while providing safe and effective medical devices to doctors and patients worldwide.